The clinical manifestation of MCAD deficiency: challenges towards adulthood in the screened population
- 8 June 2010
- journal article
- review article
- Published by Wiley in Journal of Inherited Metabolic Disease
- Vol. 33 (5), 513-520
- https://doi.org/10.1007/s10545-010-9115-5
Abstract
Medium-chain acyl-CoA dehydrogenase deficiency (MCADD) is the most common fatty acid oxidation disorder. Typically, undiagnosed individuals are asymptomatic until an episode of increased energy demand and fasting occurs, resulting in metabolic derangement. Phenotypic heterogeneity has been increasingly realized, with reports of both neonates and adults manifesting with life-threatening symptoms including encephalopathy, rhabdomyolysis, and cardiac failure. If diagnosed presymptomatically, outcome is favorable basically by avoidance of fasting. Early detection by newborn screening (NBS) has significantly reduced the incidence of severe adverse events including deaths. In this manuscript we focus on the natural course of the disease in both children and adults. Although NBS for MCADD has been successfully established, continuing efforts need to be made to avoid acute crises and deterioration of outcome in screened patients entering adolescence and adulthood.Keywords
This publication has 51 references indexed in Scilit:
- Nutrition and Athletic PerformanceMedicine & Science in Sports & Exercise, 2009
- Economic Evaluation of Tandem Mass Spectrometry Newborn Screening in AustraliaPediatrics, 2009
- Neuropsychological Functioning in Children with Medium Chain Acyl Coenzyme A Dehydrogenase Deficiency (MCADD): The Impact of Early Diagnosis and Screening on OutcomeChild Neuropsychology, 2008
- Late presentation of medium‐chain acyl‐CoA dehydrogenase deficiencyJournal of Inherited Metabolic Disease, 2006
- Newborn screening for medium‐chain acyl‐CoA dehydrogenase deficiency: A global perspectiveJournal of Inherited Metabolic Disease, 2005
- Anesthetic Considerations for a Patient with Compound Heterozygous Medium-Chain Acyl-CoA Dehydrogenase DeficiencyAnesthesia & Analgesia, 2002
- Anesthetic Considerations for a Patient with Compound Heterozygous Medium-Chain Acyl-CoA Dehydrogenase DeficiencyAnesthesia & Analgesia, 2002
- Sudden Death Beyond SidsPediatric Pathology & Laboratory Medicine, 1996
- Medium–chain acyl-coenzyme A dehydrogenase deficiency: Clinical course in 120 affected childrenThe Journal of Pediatrics, 1994
- Pulse oximetry for continuous oxygen monitoring in sick newborn infantsThe Journal of Pediatrics, 1986